Who invested in Myosin Therapeutics?
Myosin Therapeutics's investors include National Institutes of Health, Mayo Clinic, DeepWork Capital and Florida Opportunity Fund.

United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$6.5Mraised across 2 rounds since 2025, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recorded
Source recorded
From the SEC filings it signed: 1 on the team.
On the board, as filediAndrew RitterDave AdamsJackson StreeterPatrick GriffinRobert FinizioTheodore Kamenecka
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Myosin Therapeutics's investors include National Institutes of Health, Mayo Clinic, DeepWork Capital and Florida Opportunity Fund.
Myosin Therapeutics has raised $6.5M across 2 rounds since 2025.
Myosin Therapeutics's most recent round was a Grant of $2.0M in Mar 2026.
Myosin Therapeutics's largest round on record is $4.5M (Grant), in Aug 2025.
Myosin Therapeutics's first round on record, in Aug 2025, was backed by National Institutes of Health, Mayo Clinic and DeepWork Capital and 1 others.
Myosin Therapeutics's latest named round is a Grant, in Mar 2026.
Myosin Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.